• 1. Department of Pharmacy/Evidence-Based Pharmacy Centre, West China Second University Hospital, Sichuan University, Chengdu 610041, P.R.China;
  • 2. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu 610041, P.R.China;
  • 3. West China School of Medicine, Sichuan University, Chengdu 610041, P.R.China;
  • 4. Medical Management Service Guidance Center, National Health Commission of the People’s Republic of China, Beijing 100044, P.R.China;
  • 5. West China School of Pharmacy, Sichuan University, Chengdu 610041 P.R.China;
  • 6. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, P.R.China;
  • 7. West China School of Public Health, Sichuan University, Chengdu 610041, P.R.China;
  • 8. Department of Pharmacy, Peking University Third Hospital, Beijing 100191, P.R.China;
  • 9. Evidence-based Pharmacy Committee, Chinese Pharmaceutical Association, Beijing 100044, P.R.China;
  • 10. Centre for Evidence-Based Medicine, Tianjin University of TCM, Tianjin 301617, P.R.China;
  • 11. Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, P.R.China;
WANG Qiang, Email: jason2019@sina.cn; ZHANG Lingli, Email: zhanglingli@scu.edu.cn
Export PDF Favorites Scan Get Citation

Objectives To establish a tool for evaluating clinical applicability of guidelines with the users of the guidelines as evaluators.Methods The research group formed a multidisciplinary team to establish an evidence- based tool for evaluating clinical applicability of guidelines through systematic evaluation and two rounds of Delphi expert consultation and external audit.Results The established tool consisted: evaluator basic information (12 items); clinical applicability evaluation (12 items, including availability, readability, acceptability, feasibility and overall evaluation); and scoring scheme.Conclusions This study has established a tool for evaluating clinical applicability of guidelines with the users of the guidelines as evaluators and provides criteria and methods for evaluating clinical applicability of guidelines.

Citation: ZENG Linan, YI Qiusha, ZHANG Chuan, HUANG Chao, LI Hailong, YANG Chunsong, LIN Mao, HUANG Liang, LIU Dan, KANG Deying, LIU Guanjian, LIU Qiaolan, ZHAO Rongsheng, ZHANG Junhua, LI Youping, LIU Hanmin, WANG Qiang, ZHANG Lingli. Establishment of a tool for evaluating clinical applicability of guidelines. Chinese Journal of Evidence-Based Medicine, 2020, 20(4): 466-475. doi: 10.7507/1672-2531.201904131 Copy

  • Previous Article

    Interventional embolization, surgery and high intensity focused ultrasound for the treatment of uterine fibroids: a network meta-analysis
  • Next Article

    Patient safety: current situation and strategy